- Home
- SPRY vs IRS Comparison
SPRY vs IRS Comparison
Compare SPRY & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- IRS
- Stock Information
- Founded
- SPRY 2015
- IRS 1943
- Country
- SPRY United States
- IRS Argentina
- Employees
- SPRY N/A
- IRS N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- SPRY Health Care
- IRS Real Estate
- Exchange
- SPRY Nasdaq
- IRS Nasdaq
- Market Cap
- SPRY 1.4B
- IRS 1.2B
- IPO Year
- SPRY N/A
- IRS 1994
- Fundamental
- Price
- SPRY $11.41
- IRS $16.24
- Analyst Decision
- SPRY Strong Buy
- IRS Strong Buy
- Analyst Count
- SPRY 4
- IRS 1
- Target Price
- SPRY $24.00
- IRS $12.62
- AVG Volume (30 Days)
- SPRY 959.4K
- IRS 248.5K
- Earning Date
- SPRY 11-13-2024
- IRS 02-03-2025
- Dividend Yield
- SPRY N/A
- IRS 9.80%
- EPS Growth
- SPRY N/A
- IRS N/A
- EPS
- SPRY N/A
- IRS N/A
- Revenue
- SPRY $2,568,000.00
- IRS $370,002,935.00
- Revenue This Year
- SPRY $95,526.66
- IRS N/A
- Revenue Next Year
- SPRY $275.98
- IRS N/A
- P/E Ratio
- SPRY N/A
- IRS N/A
- Revenue Growth
- SPRY 8460.00
- IRS N/A
- 52 Week Low
- SPRY $5.02
- IRS $7.32
- 52 Week High
- SPRY $18.51
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- SPRY 32.88
- IRS 54.16
- Support Level
- SPRY $11.76
- IRS $16.30
- Resistance Level
- SPRY $14.50
- IRS $17.23
- Average True Range (ATR)
- SPRY 0.75
- IRS 0.78
- MACD
- SPRY -0.20
- IRS -0.19
- Stochastic Oscillator
- SPRY 1.63
- IRS 21.57
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.